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Objectives: To date, no indigenous dengue virus (DENV) transmissions have been
reported in Korea. However, imported dengue infections have been diagnosed in
travelers returning from endemic areas. This study presents the first virological
evidence of travel-associated DENV importation into South Korea.
Methods: From January 2004 to June 2006, a total of 278 serum samples from 245
patients with suspected dengue fever were tested using the Panbio Dengue Duo
IgM/IgG Rapid Strip Test. We selected 11 of the early symptomatic-phase sera
that were negative for IgM and retrospectively studied them by virus isolation
and reverse transcription-polymerase chain reaction.
Results: All 11 serum samples were found to be DENV positive by reverse
transcription-polymerase chain reaction and viruses were successfully isolated
from seven of the 11 serum samples. All the isolates were identified as DENV
serotype-1.
Conclusion: We successfully isolated seven DENV serotype-1 strains for the first
time in South Korea from imported infections. Considering that the vector
mosquito, Aedes albopictus, already exists in South Korea, we propose that
a vector surveillance program for dengue is urgently needed.1. Introduction
Dengue virus (DENV) is a single-stranded, positive-
sense RNA virus belonging to the genus Flavivirus,
family Flaviviridae [1]. The four antigenically distinct
serotypes (DENV-1, -2, -3, and -4) cause various forms
of illness, ranging from inapparent infection or classic
dengue fever (DF) to severe and life-threatening dengue
hemorrhagic fever/dengue shock syndrome [2]. DENVibuted under the terms o
y-nc/3.0) which permits un
is properly cited.
ol and Prevention. Publisheinfections are now endemic in more than 100 countries
in tropical and subtropical regions, with an estimated 50
million infections annually [3,4].
With increasing international air travel, DENV
infection is a potential risk for travelers to tropical areas
where dengue is endemic or epidemic. As the numbers
of imported cases grow, dengue is increasingly recog-
nized as a serious public health problem in non-endemic
countries [5e8]. In South Korea, the diagnosis off the Creative Commons Attribution Non-Commercial License
restricted non-commercial use, distribution, and reproduction in
d by Elsevier. All rights reserved.
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Korea National Institute of Health using a commercial
immunochromatographic test kit. To date, no indigenous
DENV transmissions have been reported in Korea.
However, cases of imported dengue infection have been
diagnosed in travelers returning from endemic or
epidemic areas. Studies of the DENV isolated from
travelers have provided useful information about the
strains circulating in tropical regions, especially in
countries that do not promptly analyze their domestic
isolates, and have revealed the emergence of novel
DENV strains and a genotype shift in countries [9,10].
Although a positive result using a commercial sero-
logic kit is one of the indications of DENV infection, it
should be confirmed using other diagnostic tools. For
this reason, since July 2006, laboratory testing in Korea
has been followed up using a reverse transcriptase-
polymerase chain reaction (RT-PCR) and virus isola-
tion. In this study, we isolated DENV serotype-1
(DENV-1) strains for the first time in Korea and
analyzed the phylogenetic relationships of these DENV-
1 isolates.2. Materials and Methods
2.1. Serum samples
Serum samples from patients with dengue-like
symptoms were forwarded to the Division of Arbovi-
ruses at Korea National Institute of Health for serologic
diagnosis. Between January 2004 and June 2006, a total
of 278 serum samples were collected. The specimens
were tested using the Panbio Dengue Duo IgM/IgG
Rapid Strip Test (PanBio, Queensland, Australia)
[11,12]. Of these, 11 early symptomatic-phase sera that
were negative in the serologic test (but in convalescent-
phase serum were positive) were further tested by virus
isolation and RT-PCR (Table 1).Table 1. Summary of the patient information
Patient code/yr Travel history Serotype by R
32/2004 IU 2
38/2004 IU 3









aTested with original serum samples; bVirus isolation and typing.
IUZ information unavailable; the dash (e) Z negative; RT-PCRZ reverse tr2.2. Virus isolation
Invertebrate C6/36 cells (CRL 1660; American Type
Culture Collection) were grown in 25 cm2 tissue culture
flasks at 30C in minimum essential medium (MEM)
supplemented with 10% fetal bovine serum (FBS),
100 U/mL penicillin, and 100 mg/mL streptomycin. The
cells were treated with 1 mL of each of the 11 sera
diluted 1:10 with MEM containing 2% FBS and anti-
biotics. After adsorption for 2 hours, the cells were
washed once with phosphate-buffered saline and
cultured in maintenance medium at 30C. The culture
supernatants were collected seven days after infection,
clarified by centrifugation, and stored at 70C for
analysis. The remaining cells were suspended in phos-
phate-buffered saline, spotted onto Teflon-coated slides,
and tested for the presence of viruses before virus typing
by immunofluorescence assay (IFA). In the IFA, the
cells were stained with commercially available mono-
clonal antibodies (mAbs; Chemicon International, CA,
USA) that were either reactive with all DENV serotypes
or were specific for individual serotypes [13]. When
viruses could not be typed with these mAbs, other mAbs
(D2-1F1-3 for DENV-1, 3H5-1-21 for DENV-2, D6-
8A1-12 for DENV-3, and 1H10-6-7 for DENV-4)
donated by the Centers for Disease Control and
Prevention (CDC, USA) were used instead [14]. Three
more passages were performed if the IFA and RT-PCR
were negative. Specimens that gave no positive result
after the third passage were regarded as negative.
2.3. Multiplex RT-PCR
To type the DENV, multiplex RT-PCR was per-
formed using the primer pairs reported by Harris et al
[15]. Viral RNA was extracted from serum samples and
culture supernatants using the QIAamp viral RNA mini
kit (Qiagen, Hilden, Germany). The RNA was reverse
transcribed and amplified using the Qiagen One Step














anscriptase-polymerase chain reaction; IFA Z immunofluorescence assay.
Table 2. Primers for amplification and sequencing of the envelope (E) gene of dengue type-1 viruses
Name Sequence (50e30) Positiona Use
D1-820-S GAGACACCCAGGATTCACGG 820e839 RT-PCR, Sequencing
D1-2600-AS TGGCTGATCGAATTCCACAC 2581e2600 RT-PCR, Sequencing
1198-S GAACTTTGTGTGYCGACGAAC 1198e1218 Sequencing
1556-S GTCCACAAACAATGGTTTC 1556e1574 Sequencing
1913-S GAAGGAACAGATGCACCATG 1913e1932 Sequencing
1440-AS GGAGCTTGAGGTGTTAT 1424e1440 Sequencing
1932-AS CATGGTGCATCTGTTCCTTC 1913e1932 Sequencing
aPosition refers to the position in the genome of the WestPac 74 strain (GenBank ID: U88535).
RT-PCR Z reverse transcriptase-polymerase chain reaction.
Table 3. Details of the dengue type-1 viruses used in this study
Strain Code Location Isolation yr GenBank IDa
RIO H 36589 Ang88 Angola 1988 AF425610
495e1 Aru88 Aruba 1985 AF425609
AUS HATI7 Aus83 Australia 1983 AF425612
BE AR 404147 Bra82 Brazil 1982 AF425613
BR/90 Bra90 Brazil 1990 S64849
BR/01-MR Bra01 Brazil 2001 AF513110
GZ/80 Chi80 China 1980 AF350498
INS 347869 Col85 Columbia 1985 AF425616
D1/H/IMTSSA/98/606 Dji98 Ethiopia 1998 AF298808
FGA/89 Fre89 French Guiana 1989 AF226687
A88 Ind88 Indonesia 1988 AB074761
98901518 DHF DV-1 Ind98 Indonesia 1998 AB189120
02-07-1HuNIID Ind02 Indonesia 2002 AB111073
SC01 Ind04 Indonesia 2004 AY858983
DenKor-02 Ind05 Indonesia 2005 EF654105
PRS 288690 Jam77 Jamaica 1977 AF425621
1298/TVP 951 Mex80 Mexico 1980 AF425623
PRS 228686 Mya76 Myanmar 1976 AF425615
My01D138862 Mya01 Myanmar 2001 AY618210
WestPac 74 WestPac 74 Nauru 1974 U88535
PRS 228682 Phi74 Philippines 1974 AF425627
01St219 Phi01 Philippines 2001 AY422777
02RBD008 Phi02 Philippines 2002 AY422778
DenKor-07 DenKor-07 Philippines 2006 EF654110
Singapore 8114/93 Sin93 Singapore 1993 AY762084
S144/02 Sin02 Singapore 2002 EU069600
T3196/04 Sin04 Singapore 2004 EU069624
DenKor-01 DenKor-01 India, Singapore 2004 EF654104
D1/SG/05K4173DK1/
2005
Sin05 Singapore 2005 EU081262
D1/SG/06K2290DK1/
2006
Sin06 Singapore 2006 EU081281
TH-SMAN Tha54 Thailand 1954 D10513
2543e63 Tha63 Thailand 1963 AF425629
16007 Tha64 Thailand 1964 AF180817
PUO 359 Tha80 Thailand 1980 AF425630
ThD1_K0229_90 Tha90 Thailand 1990 AY732466
ThD1_K0051_99 Tha99 Thailand 1999 AY732458
ThD1_0075_02 Tha02 Thailand 2002 AY732398
DenKor-05 DenKor-05 Thailand 2005 EF654108
DenKor-06 DenKor-06 Thailand 2005 EF654109
5345 Ven95 Venezuela 1995 AF425635
aThe bold ID numbers indicate the sequences that were determined in this study.
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Dengue type 1 virus in Koreans traveling abroad 37(5 mL) was added to 45 mL of reaction mixture con-
taining 10 mL of 5 reaction buffer, 0.4 mM of each of
the four dNTPs, 0.6 mM of the D1 and D2 primer pair
and 2 mL of enzyme mix. Reverse transcription was
conducted at 50C for 30 minutes, followed by dena-
turation at 95C for 15 minutes.
Thereafter, the cDNA was amplified in 30 cycles of
denaturation at 94C for 15 seconds, annealing at 58C
for 30 seconds and extension at 72C for 1 minute. The
second-round multiplex PCR used 1 mL of template,
diluted 1:100 from the initial amplification reaction.
Each reaction mixture (50 mL) contained 25 mL of 2
PCR Master Mix and 5 mL of 10 primer mix (con-
taining 2 mM of each of the D1, TS1eTS3 and DEN4
primers). The reaction was performed with the following
conditions: 95C for 15 minutes, followed by 30 cycles
of 94C for 30 seconds, 57C for 90 seconds, 72C for
30 seconds and a final extension for 5 minutes at 72C.
The RT-PCR products were analyzed by 1.5% agarose
gel electrophoresis and the serotypes were determined
according to the product sizes (DENV-1, 482 bp; DENV-2,
119 bp; DENV-3, 290 bp; and DENV-4, 389 bp).Figure 1. Identification of dengue virus (DENV) serotypes
from (A) the original serum samples and (B) culture super-
natants by multiplex RT-PCR. The patient code number is
shown at the top. Lane M Z 100-bp ladder; Lane
C Z negative control; Lane 1 Z DENV-1 (Hawaii) positive;
Lane 2 Z DENV-2 (New Guinea C) positive; Lane
3 Z DENV-3 (H87) positive; Lane 4 Z DENV-4 (H241)
positive. The expected sizes of the RT-PCR products were as
follows: DENV-1 Z 482 bp; DENV-2 Z 119 bp; DENV-
3 Z 290 bp; and DENV-4 Z 389 bp.2.4. Nucleotide sequencing and phylogenetic
analysis
The initial culture supernatants assigned to DENV-1
were used to amplify the complete envelope (E) gene
without any further passage. RT-PCR was performed
using the SuperScript III First-Strand Synthesis System
and AccuPrime Pfx DNA Polymerase (Invitrogen, CA,
USA) with the primer pairs reported by Goncalvez et al
[16]. The amplified products (w1.8 kb) were purified
with the QIAquick Gel Extraction Kit (Qiagen) and
sequenced in both directions using the ABI PRISM
BigDye Terminator Cycle Sequencing Kits and ABI
3730xl sequencer (Applied Biosystems, CA, USA)
according to the manufacturer’s instructions. At least
two independent PCR products were sequenced using
the primers listed in Table 2. The resulting nucleotide
sequences were compiled using the SeqMan program in
the Lasergene software version 5.06 (DNASTAR, WI,
USA) and identified by BLAST searches. A total of 40 E
gene sequences for DENV-1 strains were used in the
sequence comparison and phylogenetic analyses
(Table 3). Multiple alignments of the sequences were
generated using ClustalW version 1.83 with default
alignment parameters. Phylogenetic trees for aligned
nucleotide sequences were constructed with the MEGA-
4.0 [17]. The Kimura 2-parameter and Tamura-Nei
model were used as substitution models with the
neighbor-joining method available in the MEGA-4.0.
The reliability of the grouping in the trees was evalu-
ated by the bootstrap resampling method (1,000 repli-
cates). The E gene sequence of DENV-3 (GenBank ID:
NC_001475) was used as the out-group in constructing
the tree.3. Results
3.1. Virus isolation and serotyping
The presence and serotypes of DENV in the cultures
were determined by both multiplex RT-PCR and IFA.
DENV-specific RNA was detected in all 11 serum
samples (Figure 1A). A case of concurrent infection
with two serotypes of DENV (serotypes 1 and 2) was
detected in the serum sample of one patient (Patient 47).
Virus isolation was successful in seven of the 11 serum
samples (Figures 1B and 2). The seven isolates were all
assigned to DENV-1 according to the sizes of the
multiplex RT-PCR products and their reactivity against
serotype-specific antibodies.
3.2. Sequence comparison and phylogenetic
analysis
The nucleotide and deduced amino acid sequences of
the E gene (1485 bp in length) of the isolates were
compared with 35 previously published sequences for
DENV-1 strains. Of the seven isolates recovered in this
study, the E genes of DenKor-02, -03, and -4 showed
100% identity at the nucleotide sequence level. These
three strains were isolated from patients who had trav-
eled to Indonesia together (Table 1). In the following
analyses, we used DenKor-02 as the representative
isolate for all of them. Five isolates (DenKor-01, -02,
-05, -06, and -07) showed various sequence similarities,
ranging from 90.6% to 99.6% and 95.6% to 100% at the
nucleotide and amino acid levels respectively, with the
other 35 DENV-1 strains (data not shown).
Figure 2. Detection and typing of dengue virus (DENV) isolates using monoclonal antibodies. The culture of C6/36 cells injected
with patient serum (patient code. 115/2005) was harvested and stained (A) with monoclonal antibodies reactive with all DENV
serotypes (MAB 8705, Chemicon International, USA) and (B) with DENV serotype-1 specific antibodies (D2-1F1-3, Centers for
Disease Control and Prevention, USA). (C) is the negative control (non-infected C6/36 cells, reacted with MAB 8705).
Figure 3. Phylogenetic tree based on the nucleotide sequences of the envelope gene from 40 dengue type-1 viruses. The tree was
constructed by the neighbor-joining method (Tamura-Nei substitution model) and rooted using a reference strain of dengue type-3
virus (GenBank ID: NC_001475). The percentages of bootstrap values are shown at each node (1,000 replicates). Genotypes I, II,
IV and V are as defined in previous studies [16,30].
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work revealed nucleotide similarities of 90.6e99.1%
and amino acid similarities of 96.6e99.8%. The highest
nucleotide sequence similarity of 99.1% (14 nucleotide
changes and one amino acid change) was observed
between DenKor-05 and DenKor-06. Based on the
E gene sequences of DENV-1, the genetic relationships
between the 35 previously published strains and the five
isolates that showed sequence similarities to them were
determined and grouped into five genotypes according
to the genotype classification suggested in a previous
study (Figure 3) [6]. DenKor-01, isolated from a patient
who had visited India and Singapore, fell into genotype
V and grouped with a strain from Singapore. DenKor-
02, -05, and -06 clustered into genotype I. DenKor-07
fell into genotype IV and grouped with strains from
the Philippines and India.4. Discussion
Up until June 2006, we carried out laboratory diag-
noses using antibody detection with the PanBio Dengue
Duo IgM/IgG Rapid Strip Test. A positive result with
a commercial test kit is often accepted as evidence of
DENV infection [12]. However, diagnosis of DENV
infection using a commercial test kit alone is not reliable
in terms of sensitivity and specificity, and a definitive
diagnosis should be made in conjunction with other
laboratory findings [2,18]. Moreover, because vaccina-
tion against Japanese encephalitis is widely used in
South Korea [19], it is important to note that serological
cross-reactions between the two flaviviruses are prob-
able. From this viewpoint, despite a travel history to
endemic regions, some of the 74 cases diagnosed in our
laboratory can only be considered probable DENV
infections. Conversely, because most of the samples that
we obtained were single-phase sera, if the samples had
been collected prior to antibody production, some of the
test results might be false negatives. Therefore, the true
number of DENV infections might have been under-
estimated in our laboratory findings.
It is interesting that the identical DENV-1 strains
(DenKor-02, -03, and -04) were isolated from the sera of
three patients who had traveled to Indonesia together.
The possibility of cross contamination among serum
samples was excluded in our study because three inde-
pendent experiments with the original serum samples
were carried out. The possibility that several persons
were infected within a short time by a single mosquito
has been proposed in previous studies [20e23].
A dual co-infection with two serotypes of DENV
(Type 1 and 2) in a patient who had traveled to India and
Singapore in August 2004 (Patient 47) was found. The
first documented case of concurrent infections with
more than one serotype of DENV was reported in Puerto
Rico in 1982 [24]. Since then, several cases have beenreported in New Caledonia, Thailand, Somalia, Mexico,
and China [25e28]. The reason for dual infections is
explained by the unique feeding behavior of Aedes
aegypti mosquitoes. Because the female mosquito often
feeds on several individuals during a single gonotropic
cycle, there is a chance that it will be dually infected and
then transmit multiple viruses to a single individual
[22,23]. We failed to isolate both serotypes of DENV
from this patient by viral culture. Two previous studies
suggested that, in a culture, the direct competition of
viruses leads to a failure to detect the different serotypes
of DENV by RT-PCR or IFA [26,27]. It has been sug-
gested that concurrent infection might be associated
with the more severe forms of the disease [29].
However, primarily because there are too few cases
available to verify the hypothesis, this remains to be
investigated further. In the present study, we found no
association between dual infection and disease severity.
In summary, for the first time in South Korea, we
isolated seven DENV-1 strains from imported cases.
Sequence and phylogenetic analysis indicated that
frequent genetic changes occurred in DENV-1 strains
throughout the world. Importantly, because the vector
mosquito, Aedes albopictus, already exists in the
country, an extensive surveillance program should be
urgently implemented in South Korea.Acknowledgement
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